Literature DB >> 20049945

Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond.

Lina Chen1, Sun-Mi Park, Jerrold R Turner, Marcus E Peter.   

Abstract

CD95 is a member of the death receptor family. It is a prototypical inducer of apoptosis that, upon binding of its cognate ligand (CD95L), forms a death-inducing signaling complex composed of adaptor molecules and initiator caspases that transmit the apoptosis signal. The CD95/CD95L system was implicated in the etiology of inflammatory bowel disease (IBD) based, primarily, on the finding that CD95 is highly expressed in the intestinal epithelial cells and that epithelial apoptosis is increased in IBD. In recent years it has been recognized that CD95, while playing an important role as an apoptosis-inducing receptor in the immune system, also has multiple nonapoptotic functions on nonimmune cells. This review critically discusses the data on the possible function of CD95 as an apoptosis-inducing receptor in IBD and discusses alternative mechanisms for epithelial cell loss in IBD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20049945     DOI: 10.1002/ibd.21191

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  12 in total

Review 1.  The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases.

Authors:  Richard H Siggers; David J Hackam
Journal:  Cell Mol Life Sci       Date:  2011-10-11       Impact factor: 9.261

2.  Fas palmitoylation by the palmitoyl acyltransferase DHHC7 regulates Fas stability.

Authors:  A Rossin; J Durivault; T Chakhtoura-Feghali; N Lounnas; L Gagnoux-Palacios; A-O Hueber
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

3.  Redistribution of the tight junction protein ZO-1 during physiological shedding of mouse intestinal epithelial cells.

Authors:  Yanfang Guan; Alastair J M Watson; Amanda M Marchiando; Emily Bradford; Le Shen; Jerrold R Turner; Marshall H Montrose
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-23       Impact factor: 4.249

Review 4.  Immune-epithelial crosstalk at the intestinal surface.

Authors:  Nadine Wittkopf; Markus F Neurath; Christoph Becker
Journal:  J Gastroenterol       Date:  2014-01-28       Impact factor: 7.527

Review 5.  Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease.

Authors:  J Magarian Blander
Journal:  FEBS J       Date:  2016-06-22       Impact factor: 5.542

6.  Mice lacking functional CD95-ligand display reduced proliferation of the intestinal epithelium without gross homeostatic alterations.

Authors:  Kari Trumpi; Ernst J A Steller; Wendy W de Leng; Daniëlle A Raats; Isaäc J Nijman; Folkert H M Morsink; Inne H M Borel Rinkes; Onno Kranenburg
Journal:  Med Mol Morphol       Date:  2015-12-23       Impact factor: 2.309

Review 7.  Mucosal injuries due to ribosome-inactivating stress and the compensatory responses of the intestinal epithelial barrier.

Authors:  Yuseok Moon
Journal:  Toxins (Basel)       Date:  2011-10-20       Impact factor: 4.546

Review 8.  Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.

Authors:  Tomasz J Ślebioda; Zbigniew Kmieć
Journal:  Mediators Inflamm       Date:  2014-06-17       Impact factor: 4.711

Review 9.  Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases.

Authors:  Piotr Eder; Liliana Lykowska-Szuber; Kamila Stawczyk-Eder; Iwona Krela-Kaźmierczak; Krzysztof Linke
Journal:  Prz Gastroenterol       Date:  2014-10-19

10.  Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease.

Authors:  Uri Netz; Jane Victoria Carter; Maurice Robert Eichenberger; Gerald Wayne Dryden; Jianmin Pan; Shesh Nath Rai; Susan Galandiuk
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.